The Philippine situation would bring in a small amount of revenue and that’s the only foreign hope in the near to medium term in my mind. Brazil who has a much bigger problem hasn’t called us; we are calling them. The UK and Canada I’m not holding my breathe . They will most likely fall in line with the US posture. The BLA is going to be a year late since it’s rejection in my opinion and it took a back seat to two failed Covid trials . She. I say Failures I mean primary endpoint achievement did not occur . This is 10 months of shifting focus to the detriment of an application , HIV that actually mailed its trial. I believe NP got so far into Covid he couldn’t find a graceful way out , especially after the cd12 trials. This feels like the charge of the alight Brigade right now as a buyout by a big Pharma in my opinion. Is the best way forward to get Leronlimab to market